This report contains market size and forecasts of Platelet-Rich Plasma Injection in global, including the following market information: Global Platelet-Rich Plasma Injection Market Revenue, 2017-2022, 2023-2028, ($ millions) Global Platelet-Rich Plasma Injection Market Sales, 2017-2022, 2023-2028, (K Units) Global top five Platelet-Rich Plasma Injection companies in 2021 (%) The global Platelet-Rich Plasma Injection market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Leukocyte-rich (LR)-PRP Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Platelet-Rich Plasma Injection include Seikagaku Corporation, Zimmer Biomet Holdings, Orlin & Cohen, Dr. Reddy's Laboratories, Chugai Pharmaceutical, Flexion Therapeutics, Sanofi, Relievus and Teva Pharmaceutical Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Platelet-Rich Plasma Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Platelet-Rich Plasma Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units) Global Platelet-Rich Plasma Injection Market Segment Percentages, by Type, 2021 (%) Leukocyte-rich (LR)-PRP Leukocyte-poor (LP)-PRP Others Global Platelet-Rich Plasma Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units) Global Platelet-Rich Plasma Injection Market Segment Percentages, by Application, 2021 (%) Hospital Clinic Pharmacy Global Platelet-Rich Plasma Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units) Global Platelet-Rich Plasma Injection Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Platelet-Rich Plasma Injection revenues in global market, 2017-2022 (Estimated), ($ millions) Key companies Platelet-Rich Plasma Injection revenues share in global market, 2021 (%) Key companies Platelet-Rich Plasma Injection sales in global market, 2017-2022 (Estimated), (K Units) Key companies Platelet-Rich Plasma Injection sales share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Seikagaku Corporation Zimmer Biomet Holdings Orlin & Cohen Dr. Reddy's Laboratories Chugai Pharmaceutical Flexion Therapeutics Sanofi Relievus Teva Pharmaceutical Industries Wright Medical Group Anika Therapeutics Bioventus Ferring Pharmaceuticals Pfizer
1 Introduction to Research & Analysis Reports 1.1 Platelet-Rich Plasma Injection Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Platelet-Rich Plasma Injection Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research
